Lannett Company, Inc. (NYSE: LCI) today announced that it has received approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application (ANDA) of Phentermine HCl Capsules, 37.5 mg. ...
Click here to find more about phentermine hcl 375 mg
|
inShare0Share Lannett Company, Inc. (NYSE: LCI) today announced that it has received approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application (ANDA) of Phentermine HCl Capsules, 37.5 mg. Phentermine HCl Capsules, 37.5 mg, is therapeutically equivalent to the reference listed drug, Adipex-P® Capsules, 37.5 mg, of Teva Pharmaceuticals USA. Sales of Phentermine HCl Capsules, 37.5 mg, at Average Wholesale Price were approximately $8.8 million for the year ending May, 2011, according to Wolters Kluwer.
When it comes to investing, you cannot settle for anything less than the fastest and most efficient news feed. That is why we created Benzinga Pro. Sign up for a free trial today!
(c) 2011 Benzinga.com. All rights reserved. This material may not be published in its entirety or redistributed without the approval of Benzinga.
Sign up in less than 9 seconds.Already a Member? Sign in Most RecentMost ReadBenzinga's Top ETF Gainers, July 26th (BAL, TVIX, PALL, AGQ)
Trending Nowspecial dividends, Ticketmaster, ReneSola, ford motor, PFE, Nano, ID, Sprint, Intel, optionsThe Benzinga Brain Trust--Select Benzinga Brain Trust Columnist--Greg TroccoliWilliam K. BlackAndre GratianRoger VertesMark RiddixTed AllrichDaniel HoNejat SeyhunAdrienne ToghraieDan PassarelliLogan MohtashamiPatricia BriggsL.
Benzinga LikesDay Trading Radio Market Folly Plamero YCharts SMR Zero Hedge Tickerpedia NASDAQ Minyanville SeekingAlpha TheStreet CNBC Press Releases5.6% Return Seen to Date on SmarTrend Integra LifeSciences Call (IART)
